AHSCX
Price
$13.46
Change
-$0.01 (-0.07%)
Updated
Nov 19 closing price
Net Assets
65.86M
FSPHX
Price
$30.27
Change
+$0.15 (+0.50%)
Updated
Nov 19 closing price
Net Assets
6.22B
Interact to see
Advertisement

AHSCX vs FSPHX

Header iconAHSCX vs FSPHX Comparison
Open Charts AHSCX vs FSPHXBanner chart's image
Alger Health Sciences C
Price$13.46
Change-$0.01 (-0.07%)
VolumeN/A
Net Assets65.86M
Fidelity Select Health Care
Price$30.27
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets6.22B
AHSCX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
AHSCX vs. FSPHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AHSCX is a Hold and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. AHSCX (65.9M). FSPHX pays higher dividends than AHSCX: FSPHX (0.02) vs AHSCX (0.00). AHSCX was incepted earlier than FSPHX: AHSCX (24 years) vs FSPHX (44 years). AHSCX (1.90) is less costly to investors than FSPHX (0.63). AHSCX is a more actively managed with annual turnover of: 233.38 vs. FSPHX (40.00). FSPHX has a lower initial minimum investment than AHSCX: FSPHX (0) vs AHSCX (1000). AHSCX annual gain was more profitable for investors over the last year : 2.90 vs. FSPHX (0.02). FSPHX return over 5 years is better than : -8.84 vs. AHSCX (-46.80).
AHSCXFSPHXAHSCX / FSPHX
Total Expense Ratio1.900.63302%
Annual Report Gross Expense Ratio1.900.63302%
Fund Existence24 years44 years-
Gain YTD5.39910.53251%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets65.9M6.22B1%
Annual Yield % from dividends0.000.02-
Returns for 1 year2.900.0217,173%
Returns for 3 years5.5610.4753%
Returns for 5 years-46.80-8.84529%
Returns for 10 years-28.7739.34-73%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5